WATSON PHARMACEUTICALS TO CONSOLIDATE SOLID DOSAGE MANUFACTURING FACILITIES

Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced its plan to consolidate certain of its solid dosage manufacturing operations, as part of an ongoing effort to optimize the Company's manufacturing operations. Over the last several years, Watson has made significant improvements and enhancements to its solid dosage manufacturing facilities, creating the opportunity for its Carmel, NY and Corona, CA sites to absorb additional production volume.
PR Newswire